HYUNDAI BIOLAND Co.,Ltd., together with its subsidiaries, manufactures and sells cosmetic raw materials, health food raw materials, medical devices, and pharmaceutical raw materials worldwide. The company offers cosmetics, such as whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products, as well as general/health functional food ingredients. It is also involved in the provision of medical biomaterials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supplying of active pharmaceutical ingredients from herbal medicines, such as artemisiae argyi herba, corydalis tuber and pharbitis seed, and magnolia bark for pharmaceutical companies. The company was formerly known as SKbioland Co., Ltd. and changed its name to HYUNDAI BIOLAND Co.,Ltd. in October 2020. The company was founded in 1995 and is headquartered in Cheongju-si, South Korea.
Metrics to compare | 052260 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship052260PeersSector | |
---|---|---|---|---|
P/E Ratio | 11.7x | 16.5x | 12.2x | |
PEG Ratio | −0.08 | 0.05 | 0.03 | |
Price/Book | 1.1x | 1.3x | 1.5x | |
Price / LTM Sales | 1.2x | 1.3x | 0.9x | |
Upside (Analyst Target) | - | 16.7% | 16.7% | |
Fair Value Upside | Unlock | 11.7% | 10.7% | Unlock |